Navitas Semiconductor Corp
|
Brian Long
|
Director |
Sale of securities on an exchange or to another person at price $ 6.59 per share. |
04 Jun 2025 |
2,756,609 |
6,119,891
|
-
|
6.6 |
18,174,874
|
Class A Common Stock |
Navitas Semiconductor Corp
|
Ranbir Singh
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 6.76 per share. |
04 Jun 2025 |
2,000,000 |
22,390,042
|
-
|
6.8 |
13,512,600
|
Class A Common Stock |
AVITA Medical Inc
|
James M. Corbett
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
520,000 |
520,000
|
-
|
|
-
|
Stock Options (Right to Buy) |
Orasure Technologies Inc.
|
Carrie Eglinton Manner
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
335,710 |
2,024,076
(3%)
|
0%
|
|
0
|
Common Stock |
Jasper Therapeutics Inc
|
Ronald A. Martell
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
234,000 |
234,000
|
-
|
|
-
|
Stock Option (right to buy) |
Navitas Semiconductor Corp
|
Brian Long
|
Director |
Sale of securities on an exchange or to another person at price $ 6.87 per share. |
04 Jun 2025 |
198,900 |
5,920,991
|
-
|
6.9 |
1,365,588
|
Class A Common Stock |
NovoCure Ltd
|
Francis Leonard
|
EVP, Pres., Novocure Oncology |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
179,426 |
347,878
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
150,240 |
2,618,087
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
150,240 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Orasure Technologies Inc.
|
Carrie Eglinton Manner
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.90 per share. |
04 Jun 2025 |
146,000 |
1,878,076
(3%)
|
0%
|
2.9 |
423,400
|
Common Stock |
FibroGen Inc
|
James A. Schoeneck
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
120,000 |
120,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
FibroGen Inc
|
Jeffrey L. Edwards
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
120,000 |
120,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
FibroGen Inc
|
Maykin Ho
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
120,000 |
120,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Sale of securities on an exchange or to another person at price $ 119.79 per share. |
04 Jun 2025 |
101,783 |
478,091
(0%)
|
0%
|
119.8 |
12,192,535
|
Class A Common Stock |
Shimmick Corp.
|
Joseph Del Guercio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
100,671 |
100,671
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Peter Kravitz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
100,671 |
100,671
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Geoffrey E. Heekin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
100,671 |
100,671
|
-
|
|
-
|
Restricted Stock Units |
Jasper Therapeutics Inc
|
Edwin Jonathan Tucker
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (right to buy) |
Jasper Therapeutics Inc
|
Jeetinder Singh Mahal
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (right to buy) |
Abacus Life Inc - Ordinary...
|
Kevin Scott Kirby
|
Co-Founder and President, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 5.77 per share. |
04 Jun 2025 |
86,207 |
12,447,415
|
-
|
5.8 |
497,759
|
Common Stock |
Abacus Life Inc - Ordinary...
|
Tod Sean McNealy
|
Director, Co-Founder and President, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 5.77 per share. |
04 Jun 2025 |
86,207 |
12,455,707
|
-
|
5.8 |
497,759
|
Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
85,637 |
2,532,450
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
85,637 |
538,406
(0%)
|
0%
|
0.3 |
26,265
|
Class A Common Stock |
Shimmick Corp.
|
Joseph Del Guercio
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
0
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Joseph Del Guercio
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
123,905
|
-
|
|
-
|
Common Stock, par value $0.01 per share |
Shimmick Corp.
|
J. Brendan Herron
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
0
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
J. Brendan Herron
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
155,778
|
-
|
|
-
|
Common Stock, par value $0.01 per share |
Shimmick Corp.
|
Carolyn Luther Trabuco
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
0
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Carolyn Luther Trabuco
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
96,046
|
-
|
|
-
|
Common Stock, par value $0.01 per share |
Shimmick Corp.
|
Peter Kravitz
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
84,269
|
-
|
|
-
|
Common Stock, par value $0.01 per share |
Shimmick Corp.
|
Peter Kravitz
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
0
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Geoffrey E. Heekin
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
0
|
-
|
|
-
|
Restricted Stock Units |
Shimmick Corp.
|
Geoffrey E. Heekin
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
84,269 |
108,778
|
-
|
|
-
|
Common Stock, par value $0.01 per share |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
|
04 Jun 2025 |
83,333 |
83,333
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
|
04 Jun 2025 |
83,333 |
36,903,558
|
-
|
|
-
|
Class B Common Stock |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 33.21 per share. |
04 Jun 2025 |
83,333 |
0
(0%)
|
0%
|
33.2 |
2,767,272
|
Class A Common Stock |
Viavi Solutions Inc
|
Ilan Daskal
|
EVP, CFO |
Sale of securities on an exchange or to another person at price $ 9.28 per share. |
04 Jun 2025 |
82,095 |
0
(0%)
|
0%
|
9.3 |
761,842
|
Common Stock |
GCT Semiconductor Holding ...
|
Hyunsoo Hans Shin
|
Director, Class II Director |
Purchase of securities on an exchange or from another person at price $ 1.02 per share. |
04 Jun 2025 |
80,000 |
327,248
|
-
|
1.0 |
81,600
|
Common Stock |
Turning Point Brands Inc
|
David E. Glazek
|
Director, Executive Chairman |
|
04 Jun 2025 |
78,000 |
78,000
|
-
|
|
-
|
Forward contract |
Immunic Inc
|
Joerg Neermann
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.77 per share. |
04 Jun 2025 |
70,000 |
170,000
(1%)
|
0%
|
0.8 |
53,900
|
Common Stock |
TMC the metals company Inc
|
Andrew Hall
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
66,508 |
359,267
|
-
|
|
0
|
Common Shares |
Pacific Biosciences of Cal...
|
Kathy P. Ordonez
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
Lucy Shapiro
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
Marshall L. Mohr
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
Randall S. Livingston
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
William W. Ericson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
John F. Milligan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Pacific Biosciences of Cal...
|
Hannah A. Valantine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Healthpeak Properties Inc.
|
Scott M. Brinker
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2025 |
64,095 |
64,095
|
-
|
|
-
|
OP Units |
Healthpeak Properties Inc.
|
Scott M. Brinker
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2025 |
64,095 |
306,353
|
-
|
|
-
|
OP Units |
GCT Semiconductor Holding ...
|
Hyunsoo Hans Shin
|
Director, Class II Director |
Purchase of securities on an exchange or from another person at price $ 1.03 per share. |
04 Jun 2025 |
58,700 |
385,948
|
-
|
1.0 |
60,461
|
Common Stock |
Clean Harbors, Inc.
|
Alan S. McKim
|
Director, EXEC CHAIR, CTO. |
Sale of securities on an exchange or to another person at price $ 223.80 per share. |
04 Jun 2025 |
58,156 |
2,297,896
(4%)
|
0%
|
223.8 |
13,015,313
|
Common Stock |
Boston Scientific Corp.
|
Joseph M. Fitzgerald
|
EVP & Group Pres, Cardiology |
Sale of securities on an exchange or to another person at price $ 102.88 per share. |
04 Jun 2025 |
56,372 |
178,342
(0%)
|
0%
|
102.9 |
5,799,630
|
Common Stock |
Boston Scientific Corp.
|
Joseph M. Fitzgerald
|
EVP & Group Pres, Cardiology |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. |
04 Jun 2025 |
56,372 |
234,714
(0%)
|
0%
|
26.2 |
1,474,128
|
Common Stock |
Boston Scientific Corp.
|
Joseph M. Fitzgerald
|
EVP & Group Pres, Cardiology |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
56,372 |
250,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Prime Medicine Inc
|
Kaye Foster
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Prime Medicine Inc
|
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Prime Medicine Inc
|
David P. Schenkein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Prime Medicine Inc
|
Jeffrey D. Marrazzo
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Prime Medicine Inc
|
Wendy K. Chung
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Prime Medicine Inc
|
Thomas Cahill
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
54,000 |
2,586,450
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
54,000 |
216,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Xeris Biopharma Holdings Inc
|
Jeffrey W. Sherman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
214,380
(0%)
|
0%
|
|
0
|
Common Stock |
Xeris Biopharma Holdings Inc
|
John H. Johnson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
940,983
(3%)
|
0%
|
|
0
|
Common Stock |
Xeris Biopharma Holdings Inc
|
Marla S. Persky
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
157,500
(0%)
|
0%
|
|
0
|
Common Stock |
Xeris Biopharma Holdings Inc
|
Garheng Kong
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
214,144
(0%)
|
0%
|
|
0
|
Common Stock |
Xeris Biopharma Holdings Inc
|
B. J. Bormann
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
157,500
(0%)
|
0%
|
|
0
|
Common Stock |
Xeris Biopharma Holdings Inc
|
Dawn Halkuff
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
157,500
(0%)
|
0%
|
|
0
|
Common Stock |
Cogent Communications Hold...
|
David Schaeffer
|
Director, CHAIRMAN, CEO, AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 47.76 per share. |
04 Jun 2025 |
50,000 |
3,881,721
(8%)
|
0%
|
47.8 |
2,388,040
|
common stock |
Core Scientific Inc - Ordi...
|
Todd M. Duchene
|
See remarks |
Sale of securities on an exchange or to another person at price $ 12.31 per share. |
04 Jun 2025 |
50,000 |
2,050,102
|
-
|
12.3 |
615,745
|
Common Stock |
CryoPort Inc
|
Jerrell W. Shelton
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. |
04 Jun 2025 |
50,000 |
862,419
(2%)
|
0%
|
5 |
250,000
|
Common Stock |
CryoPort Inc
|
Jerrell W. Shelton
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
50,000 |
556,064
|
-
|
|
-
|
Stock Option (right to buy) |
Orasure Technologies Inc.
|
Carrie Eglinton Manner
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.90 per share. |
04 Jun 2025 |
47,249 |
1,830,827
(2%)
|
0%
|
2.9 |
137,022
|
Common Stock |
Annovis Bio Inc
|
Maria Maccecchini
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 3.37 per share. |
04 Jun 2025 |
46,000 |
1,114,459
(17%)
|
0%
|
3.4 |
155,020
|
Common Stock |
UiPath Inc - Ordinary Shar...
|
Daniel Dines
|
Director, CEO and Chairman, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 12.94 per share. |
04 Jun 2025 |
45,000 |
6,318,376
|
-
|
12.9 |
582,480
|
Class A Common Stock |
Cogent Biosciences Inc
|
Arlene M. Morris
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cogent Biosciences Inc
|
Matthew E. Ros
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cogent Biosciences Inc
|
Karen Jean Ferrante
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cogent Biosciences Inc
|
Todd E. Shegog
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cogent Biosciences Inc
|
Peter Harwin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cogent Biosciences Inc
|
Christopher W. Cain
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
44,700 |
44,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Clean Harbors, Inc.
|
Alan S. McKim
|
Director, EXEC CHAIR, CTO. |
Sale of securities on an exchange or to another person at price $ 225.40 per share. |
04 Jun 2025 |
41,844 |
2,356,052
(4%)
|
0%
|
225.4 |
9,431,638
|
Common Stock |
Climb Bio Inc.
|
Douglas E. Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Climb Bio Inc.
|
Kimberlee Cobleigh Drapkin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Climb Bio Inc.
|
Alexander G. Cumbo
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Climb Bio Inc.
|
Andrew Levin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Climb Bio Inc.
|
Judith A. Dunn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Climb Bio Inc.
|
Stephen Thomas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Itron Inc.
|
Thomas L. Deitrich
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
35,461 |
2,496
|
-
|
|
-
|
Stock Option (Right to Buy) |
Itron Inc.
|
Thomas L. Deitrich
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.05 per share. |
04 Jun 2025 |
35,461 |
297,489
(0%)
|
0%
|
40.0 |
1,420,213
|
Common Stock |
Beam Therapeutics Inc
|
Graham K. Cooper
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
John M. Maraganore
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
Mark C. Fishman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
Kathleen E. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
Christi Shaw
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
Chirfi Guindo
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
Beam Therapeutics Inc
|
Carole Ho
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,662 |
33,662
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
Martin J. Madden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
33,393 |
33,393
|
-
|
|
-
|
Stock Option (Right to Buy) |
Abacus Life Inc - Ordinary...
|
William H. McCauley
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 5.82 per share. |
04 Jun 2025 |
33,000 |
87,000
|
-
|
5.8 |
192,156
|
Common Stock |
Itron Inc.
|
Thomas L. Deitrich
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 119.66 per share. |
04 Jun 2025 |
31,751 |
265,738
(0%)
|
0%
|
119.7 |
3,799,331
|
Common Stock |
Navitas Semiconductor Corp
|
Brian Long
|
Director |
Sale of securities on an exchange or to another person at price $ 6.83 per share. |
04 Jun 2025 |
31,460 |
0
|
-
|
6.8 |
214,872
|
Class A Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
30,780 |
2,555,670
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
30,780 |
569,186
(0%)
|
0%
|
0.9 |
27,985
|
Class A Common Stock |
Immunic Inc
|
Joerg Neermann
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.76 per share. |
04 Jun 2025 |
30,000 |
200,000
(1%)
|
0%
|
0.8 |
22,800
|
Common Stock |
Chipotle Mexican Grill
|
Curtis Evander Garner
|
Pres, Chief Strgy & Tech Off |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
279,100
|
-
|
|
-
|
2019 SOSARs |
Chipotle Mexican Grill
|
Curtis Evander Garner
|
Pres, Chief Strgy & Tech Off |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.66 per share. |
04 Jun 2025 |
30,000 |
448,482
(1%)
|
0%
|
11.7 |
349,650
|
common stock |
Generation Bio Co
|
Charles A. Rowland
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Gustav A. Christensen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
60,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Jeffrey M. Jonas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Anthony G. Quinn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Jason P. Rhodes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Ronald Harold Wilfred Cooper
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Catherine Stehman-Breen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Donald W. Nicholson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Generation Bio Co
|
Dannielle Appelhans
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Figs Inc - Ordinary Shares...
|
Jeffrey A. Wilke
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
212,121
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
Melanie Whelan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
40,227
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
Mario J. Marte
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
70,590
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
Sheila Antrum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
100,207
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
John Martin Willhite
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
3,247,639
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
Kenneth Lin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
146,249
|
-
|
|
0
|
Class A Common Stock |
Figs Inc - Ordinary Shares...
|
Jerry Jao
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
29,412 |
82,263
|
-
|
|
0
|
Class A Common Stock |
MFA Financial Inc
|
Laurie S. Goodman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
27,984 |
143,864
|
-
|
|
-
|
Restricted Stock Units |
Vail Resorts Inc.
|
Robert A. Katz
|
Director, CEO & Chairperson of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
25,086 |
25,086
|
-
|
|
-
|
Share Appreciation Right |
Cedar Fair L.P.
|
Richard A. Zimmerman
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.11 per share. |
04 Jun 2025 |
25,071 |
717,228
(1%)
|
0%
|
33.1 |
830,101
|
Common Stock, par value $0.01 per share |
Cogent Communications Hold...
|
David Schaeffer
|
Director, CHAIRMAN, CEO, AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 47.76 per share. |
04 Jun 2025 |
25,000 |
3,856,721
(8%)
|
0%
|
47.8 |
1,193,943
|
common stock |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. |
04 Jun 2025 |
25,000 |
257,112
(0%)
|
0%
|
109.8 |
2,745,500
|
Class A Common Stock |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
25,000 |
68,835
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
25,000 |
93,835
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Sale of securities on an exchange or to another person at price $ 370.00 per share. |
04 Jun 2025 |
25,000 |
232,112
(0%)
|
0%
|
370 |
9,250,000
|
Class A Common Stock |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. |
04 Jun 2025 |
25,000 |
257,112
(0%)
|
0%
|
109.8 |
2,745,500
|
Class A Common Stock |
Visa Inc - Ordinary Shares...
|
Rajat Taneja
|
PRESIDENT, TECHNOLOGY |
Sale of securities on an exchange or to another person at price $ 367.75 per share. |
04 Jun 2025 |
25,000 |
232,112
(0%)
|
0%
|
367.7 |
9,193,688
|
Class A Common Stock |
Torrid Holdings Inc
|
Michael A. Shaffer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
24,558 |
111,616
|
-
|
|
0
|
Common Stock |
Torrid Holdings Inc
|
Theophlius Killion
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
24,558 |
103,680
|
-
|
|
0
|
Common Stock |
Stagwell Inc - Ordinary Sh...
|
Charlene Barshefsky
|
Director |
Purchase of securities on an exchange or from another person at price $ 4.31 per share. |
04 Jun 2025 |
24,350 |
185,316
|
-
|
4.3 |
104,827
|
Class A Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Sale of securities on an exchange or to another person at price $ 120.61 per share. |
04 Jun 2025 |
24,122 |
453,969
(0%)
|
0%
|
120.6 |
2,909,407
|
Class A Common Stock |
Chipotle Mexican Grill
|
Curtis Evander Garner
|
Pres, Chief Strgy & Tech Off |
Sale of securities on an exchange or to another person at price $ 52.14 per share. |
04 Jun 2025 |
23,302 |
418,482
(1%)
|
0%
|
52.1 |
1,214,894
|
common stock |
Paycom Software Inc
|
Chad Richison
|
Director, CEO, President and Chairman, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 265.20 per share. |
04 Jun 2025 |
23,200 |
3,224,049
(5%)
|
0%
|
265.2 |
6,152,640
|
Common Stock |
GCT Semiconductor Holding ...
|
Hyunsoo Hans Shin
|
Director, Class II Director |
Purchase of securities on an exchange or from another person at price $ 1.02 per share. |
04 Jun 2025 |
21,300 |
407,248
|
-
|
1.0 |
21,726
|
Common Stock |
Datadog Inc - Ordinary Sha...
|
David Obstler
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
20,000 |
35,603
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
David Obstler
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 120.25 per share. |
04 Jun 2025 |
20,000 |
399,270
(0%)
|
0%
|
120.3 |
2,405,000
|
Class A Common Stock |
Datadog Inc - Ordinary Sha...
|
David Obstler
|
Chief Financial Officer |
|
04 Jun 2025 |
20,000 |
419,270
(0%)
|
0%
|
1.6 |
31,000
|
Class A Common Stock |
Datadog Inc - Ordinary Sha...
|
David Obstler
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
20,000 |
65,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Datadog Inc - Ordinary Sha...
|
David Obstler
|
Chief Financial Officer |
|
04 Jun 2025 |
20,000 |
15,603
|
-
|
|
-
|
Class B Common Stock |
Alphabet Inc - Ordinary Sh...
|
Sundar Pichai
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 168.42 per share. |
04 Jun 2025 |
19,550 |
2,600,646
(0%)
|
0%
|
168.4 |
3,292,631
|
Class C Capital Stock |
Acumen Pharmaceuticals Inc
|
Kimberlee Cobleigh Drapkin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Acumen Pharmaceuticals Inc
|
Jeffrey L. Ives
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Acumen Pharmaceuticals Inc
|
Derrell D. Porter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Acumen Pharmaceuticals Inc
|
Sean Stalfort
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Acumen Pharmaceuticals Inc
|
Nathan B. Fountain
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Acumen Pharmaceuticals Inc
|
Laura Stoppel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
19,500 |
19,500
|
-
|
|
-
|
Stock Option (right to buy) |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
18,750 |
2,574,420
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
18,750 |
525,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
|
04 Jun 2025 |
18,750 |
9,025,030
|
-
|
|
-
|
Class B Common Stock |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 33.21 per share. |
04 Jun 2025 |
18,750 |
0
(0%)
|
0%
|
33.2 |
622,648
|
Class A Common Stock |
Pinterest Inc - Ordinary S...
|
Benjamin Silbermann
|
Director, Ten Percent Owner |
|
04 Jun 2025 |
18,750 |
18,750
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Fabrinet
|
Harpal Gill
|
PRESIDENT & COO |
Sale of securities on an exchange or to another person at price $ 240.00 per share. |
04 Jun 2025 |
18,675 |
18,068
(0%)
|
0%
|
240.0 |
4,482,019
|
Ordinary Shares |
Kinder Morgan Inc - Ordina...
|
Martin A. Thomas
|
President |
Sale of securities on an exchange or to another person at price $ 28.26 per share. |
04 Jun 2025 |
18,000 |
771,652
(0%)
|
0%
|
28.3 |
508,676
|
Class P Common Stock |
First American Financial Corp
|
Dennis J. Gilmore
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2025 |
17,544 |
475,680
(0%)
|
0%
|
|
0
|
Common Stock |
NovoCure Ltd
|
Gabriel Leung
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
Timothy John Scannell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
David T. Hung
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
Jeryl L. Hilleman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
W. Anthony Vernon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
Kristin Stafford
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
NovoCure Ltd
|
Allyson J. Ocean
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,697 |
16,697
|
-
|
|
-
|
Stock Option (Right to Buy) |
Navitas Semiconductor Corp
|
Ranbir Singh
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 6.43 per share. |
04 Jun 2025 |
16,377 |
0
|
-
|
6.4 |
105,306
|
Class A Common Stock |
PepGen Inc
|
Laurie B. Keating
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,000 |
16,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
PepGen Inc
|
Heidi Henson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,000 |
16,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
PepGen Inc
|
Joshua Resnick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,000 |
16,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
PepGen Inc
|
Habib Joseph Dable
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,000 |
16,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
PepGen Inc
|
Howard Mayer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
16,000 |
16,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
MFA Financial Inc
|
Lisa Polsky
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,840 |
78,255
|
-
|
|
-
|
Restricted Stock Units |
MFA Financial Inc
|
Robin Josephs
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,840 |
96,263
|
-
|
|
-
|
Restricted Stock Units |
MFA Financial Inc
|
Sheila A. Stamps
|
Director |
Grant, award, or other acquisition of securities at price $ 9.47 per share. |
04 Jun 2025 |
15,840 |
15,840
(0%)
|
0%
|
9.5 |
150,005
|
Common Stock, par value $0.01 per share |
MFA Financial Inc
|
Richard C. Wald
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,840 |
78,255
|
-
|
|
-
|
Restricted Stock Units |
MFA Financial Inc
|
Christopher Small
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,840 |
15,840
|
-
|
|
-
|
Restricted Stock Units |
McCormick & Co., Inc. - Or...
|
Lawrence E. Kurzius
|
Ten Percent Owner |
|
04 Jun 2025 |
15,654 |
0
(0%)
|
0%
|
73.1 |
1,144,938
|
Common Stock - Voting |
Silvaco Group Inc.
|
Katherine S. Ngai-Pesic
|
Director, Ten Percent Owner, Member of 10% owner group |
Sale of securities on an exchange or to another person at price $ 4.91 per share. |
04 Jun 2025 |
15,000 |
10,477,355
|
-
|
4.9 |
73,670
|
Common Stock |
Fuel Tech Inc
|
Dennis L. Zeitler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Restricted Stock Units |
Fuel Tech Inc
|
Douglas G. Bailey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Restricted Stock Units |
Fuel Tech Inc
|
Sharon L. Jones
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Restricted Stock Units |
Turning Point Brands Inc
|
Lawrence S. Wexler
|
Director |
Sale of securities on an exchange or to another person at price $ 74.61 per share. |
04 Jun 2025 |
15,000 |
355,186
(1%)
|
0%
|
74.6 |
1,119,150
|
Common Stock |
Acadia Pharmaceuticals Inc
|
Laura A. Brege
|
Director |
Sale of securities on an exchange or to another person at price $ 21.78 per share. |
04 Jun 2025 |
14,446 |
15,095
(0%)
|
0%
|
21.8 |
314,634
|
Common Stock |
MetaVia Inc.
|
Marshall Woodworth
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 0.70 per share. |
04 Jun 2025 |
14,200 |
44,279
(0%)
|
0%
|
0.7 |
9,940
|
Common Stock |
Akebia Therapeutics Inc.
|
Richard C. Malabre
|
SVP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 3.53 per share. |
04 Jun 2025 |
13,334 |
266,914
(0%)
|
0%
|
3.5 |
47,069
|
Common Stock |
Alphabet Inc - Ordinary Sh...
|
Sundar Pichai
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 169.16 per share. |
04 Jun 2025 |
12,950 |
2,587,696
(0%)
|
0%
|
169.2 |
2,190,604
|
Class C Capital Stock |
Acumen Pharmaceuticals Inc
|
Kimberlee Cobleigh Drapkin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
12,800
|
-
|
|
0
|
Common Stock |
Acumen Pharmaceuticals Inc
|
Jeffrey L. Ives
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
12,800
|
-
|
|
0
|
Common Stock |
Acumen Pharmaceuticals Inc
|
Derrell D. Porter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
12,800
|
-
|
|
0
|
Common Stock |
Acumen Pharmaceuticals Inc
|
Sean Stalfort
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
185,124
|
-
|
|
0
|
Common Stock |
Acumen Pharmaceuticals Inc
|
Nathan B. Fountain
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
19,050
|
-
|
|
0
|
Common Stock |
Acumen Pharmaceuticals Inc
|
Laura Stoppel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
12,800 |
12,800
|
-
|
|
0
|
Common Stock |
Fuel Tech Inc
|
Sharon L. Jones
|
Director |
Sale of securities on an exchange or to another person at price $ 1.67 per share. |
04 Jun 2025 |
12,627 |
83,972
(0%)
|
0%
|
1.7 |
21,043
|
Common Stock |
Transact Technologies Inc.
|
Steven A. DeMartino
|
President, CFO, Treas. & Secr. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
12,500 |
62,500
|
-
|
|
-
|
Restricted Stock Units |
Semtech Corp.
|
Mark Lin
|
EVP and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
12,321 |
26,435
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
Mark Lin
|
EVP and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
12,321 |
0
|
-
|
|
-
|
Restricted Stock Unit |
CarGurus Inc - Ordinary Sh...
|
Javier Esquivel Zamora
|
General Counsel and Secretary |
Sale of securities on an exchange or to another person at price $ 31.37 per share. |
04 Jun 2025 |
12,265 |
102,723
(0%)
|
0%
|
31.4 |
384,753
|
Class A Common Stock |
Semtech Corp.
|
Asaf Silberstein
|
EVP and COO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
12,004 |
116,092
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
Asaf Silberstein
|
EVP and COO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
12,004 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Socket Mobile Inc
|
Charlie Bass
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,500 |
1,603,151
(26%)
|
0%
|
|
0
|
Common Stock |
Cedar Fair L.P.
|
Brian C. Witherow
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.11 per share. |
04 Jun 2025 |
11,245 |
314,234
(0%)
|
0%
|
33.1 |
372,322
|
Common Stock, par value $0.01 per share |
NovoCure Ltd
|
Gabriel Leung
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
92,444
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
Timothy John Scannell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
17,233
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
David T. Hung
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
23,410
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
Jeryl L. Hilleman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
16,806
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
W. Anthony Vernon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
179,102
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
Kristin Stafford
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
14,269
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NovoCure Ltd
|
Allyson J. Ocean
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
11,215 |
14,269
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Cedar Fair L.P.
|
Tim V. Fisher
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.11 per share. |
04 Jun 2025 |
11,143 |
263,184
(0%)
|
0%
|
33.1 |
368,945
|
Common Stock, par value $0.01 per share |
Semtech Corp.
|
Madhusudhan Rayabhari
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,897 |
67,012
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
Madhusudhan Rayabhari
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,897 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
10,688 |
2,563,732
|
-
|
|
-
|
Class B Common Stock |
Datadog Inc - Ordinary Sha...
|
Alexis Le-Quoc
|
Director, Chief Technology Officer |
|
04 Jun 2025 |
10,688 |
579,874
(0%)
|
0%
|
10.7 |
114,789
|
Class A Common Stock |
Civitas Resources Inc - Or...
|
James M. Trimble
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
53,960
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Howard A. Willard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
50,317
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Jeffrey E. Wojahn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
48,847
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Wouter Van Kempen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
27,436
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Lloyd W. Helms
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
12,096
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Carrie L. Hudak
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
42,017
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Morris R. Clark
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
43,317
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Carrie M. Fox
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
61,393
|
-
|
|
0
|
Common Stock |
Civitas Resources Inc - Or...
|
Deborah L. Byers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,512 |
20,286
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Carl L. Gordon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Jean-Jacques Bienaime
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Tomer Kariv
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Ran Nussbaum
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Alpna Seth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Nima Farzan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Keros Therapeutics Inc
|
Julius Knowles
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,500 |
10,500
|
-
|
|
-
|
Stock Option (right to buy) |
Ameresco Inc. - Ordinary S...
|
Nickolas Stavropoulos
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,435 |
10,435
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Joseph Sutton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,435 |
10,435
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Frank V. Wisneski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,435 |
10,435
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Jennifer L. Miller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,435 |
10,435
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Claire D'Oyly-Hughes Johnson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,435 |
10,435
|
-
|
|
-
|
Restricted Stock Unit |
Funko Inc - Ordinary Share...
|
Charles D. Denson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
178,673
(0%)
|
0%
|
|
0
|
CLASS A COMMON STOCK |
Funko Inc - Ordinary Share...
|
Charles D. Denson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Trevor A. Edwards
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
16,234
(0%)
|
0%
|
|
0
|
CLASS A COMMON STOCK |
Funko Inc - Ordinary Share...
|
Trevor A. Edwards
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Diane M. Irvine
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Diane M. Irvine
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
24,573
(0%)
|
0%
|
|
0
|
CLASS A COMMON STOCK |
Funko Inc - Ordinary Share...
|
Sarah Kirshbaum Levy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Sarah Kirshbaum Levy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
23,473
(0%)
|
0%
|
|
0
|
CLASS A COMMON STOCK |
Funko Inc - Ordinary Share...
|
Jesse Jacobs
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Jesse Jacobs
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
17,067
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Funko Inc - Ordinary Share...
|
Michael Kerns
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
0
|
-
|
|
-
|
Restricted Stock Units |
Funko Inc - Ordinary Share...
|
Michael Kerns
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,204 |
13,081
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Devon Energy Corp.
|
John E. Bethancourt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,061 |
115,963
(0%)
|
0%
|
|
0
|
Common Stock |
AVITA Medical Inc
|
Jeremy L. Curnock Cook
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
39,836
|
-
|
|
-
|
Common Stock |
AVITA Medical Inc
|
Robert E. Mcnamara
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
66,771
|
-
|
|
-
|
Common Stock |
AVITA Medical Inc
|
Jan Stern Reed
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
51,011
|
-
|
|
-
|
Common Stock |
AVITA Medical Inc
|
Cary G. Vance
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
35,771
|
-
|
|
-
|
Common Stock |
AVITA Medical Inc
|
Louis J. Panaccio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
56,428
|
-
|
|
-
|
Common Stock |
AVITA Medical Inc
|
Suzanne Crowe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,022 |
46,934
|
-
|
|
-
|
Common Stock |
Airgain Inc
|
Arthur M. Toscanini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. |
04 Jun 2025 |
10,000 |
99,956
(1%)
|
0%
|
1.6 |
16,000
|
Common Stock |
Airgain Inc
|
Arthur M. Toscanini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Anixa Biosciences Inc
|
Amit Kumar
|
Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 2.85 per share. |
04 Jun 2025 |
10,000 |
569,925
(2%)
|
0%
|
2.9 |
28,500
|
Common Stock |
Princeton Bancorp Inc
|
Stephen K. Shueh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,000 |
0
|
-
|
|
-
|
Option to purchase |
Princeton Bancorp Inc
|
Stephen K. Shueh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.17 per share. |
04 Jun 2025 |
10,000 |
30,838
(0%)
|
0%
|
18.2 |
181,700
|
Common Stock |
Donaldson Co. Inc.
|
Richard Brent Lewis
|
President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. |
04 Jun 2025 |
10,000 |
41,201
(0%)
|
0%
|
35.8 |
358,000
|
Common Stock |
Donaldson Co. Inc.
|
Richard Brent Lewis
|
President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
10,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Glatfelter Corporation
|
Michael Curless
|
Director |
Purchase of securities on an exchange or from another person at price $ 12.29 per share. |
04 Jun 2025 |
10,000 |
10,000
(0%)
|
0%
|
12.3 |
122,939
|
Common Stock, Par Value $.01 |
NeuroOne Medical Technolog...
|
Mark Christianson
|
Business Development Director |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
04 Jun 2025 |
10,000 |
261,491
|
-
|
0.6 |
5,804
|
Common Stock |
Socket Mobile Inc
|
Bill Parnell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
10,000 |
81,850
(1%)
|
0%
|
|
0
|
Common Stock |
Enact Holdings Inc
|
Robert P. Restrepo
|
Director |
Sale of securities on an exchange or to another person at price $ 34.72 per share. |
04 Jun 2025 |
10,000 |
15,000
|
-
|
34.7 |
347,150
|
Common Stock |
Socket Mobile Inc
|
Ivan Lazarev
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
9,000 |
30,542
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
J. Michael Wilson
|
Chief Quality Officer and CTO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,364 |
69,314
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
J. Michael Wilson
|
Chief Quality Officer and CTO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,364 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Transact Technologies Inc.
|
Steven A. DeMartino
|
President, CFO, Treas. & Secr. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,209 |
140,638
(1%)
|
0%
|
|
0
|
Common Stock |
Booz Allen Hamilton Holdin...
|
Charles O. Rossotti
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2025 |
8,088 |
5,999
(0%)
|
0%
|
|
0
|
Class A Common Stock |
PCB Bancorp.
|
Henry Kim
|
Director, PRESIDENT, CEO & DIRECTOR |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,000 |
0
|
-
|
|
-
|
Stock option (right to buy) |
PCB Bancorp.
|
Henry Kim
|
Director, PRESIDENT, CEO & DIRECTOR |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.33 per share. |
04 Jun 2025 |
8,000 |
228,199
(1%)
|
0%
|
10.3 |
82,640
|
Common Stock |
Progyny Inc
|
Michael Sturmer
|
PRESIDENT |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.98 per share. |
04 Jun 2025 |
7,977 |
305,083
(0%)
|
0%
|
22.0 |
175,334
|
Common Stock |
Box Inc - Ordinary Shares ...
|
Aaron Levie
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Jun 2025 |
7,900 |
2,972,780
(1%)
|
0%
|
|
0
|
Class A Common Stock |
Semtech Corp.
|
William Ross Gray
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,639 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
William Ross Gray
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,639 |
20,074
(0%)
|
0%
|
|
0
|
Common Stock |
Semtech Corp.
|
Imran Sherazi
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,639 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Imran Sherazi
|
SVP and GM |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,639 |
12,908
(0%)
|
0%
|
|
0
|
Common Stock |
Globe Life Inc
|
Frank M. Svoboda
|
Director, Co-Chairman & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 82.56 per share. |
04 Jun 2025 |
7,500 |
38,798
(0%)
|
0%
|
82.6 |
619,200
|
Common Stock |
Globe Life Inc
|
Frank M. Svoboda
|
Director, Co-Chairman & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,500 |
50,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Donaldson Co. Inc.
|
Richard Brent Lewis
|
President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.29 per share. |
04 Jun 2025 |
7,369 |
33,832
(0%)
|
0%
|
69.3 |
510,598
|
Common Stock |
Devon Energy Corp.
|
Barbara M. Baumann
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
95,880
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Karl F. Kurz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
88,748
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Kelt Kindick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
39,486
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Michael N. Mears
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
18,442
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Robert A. Mosbacher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
90,762
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Valerie M. Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
46,467
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Ann G. Fox
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
43,676
(0%)
|
0%
|
|
0
|
Common Stock |
Devon Energy Corp.
|
Gennifer F. Kelly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,288 |
18,442
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
Travis D. Smith
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
41,478
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
James Murphy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
28,121
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
Steven P. Louden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
25,225
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
Liliana Gil Valletta
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
17,409
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
Carmen R. Bauza
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
17,409
(0%)
|
0%
|
|
0
|
Common Stock |
Zumiez Inc
|
Guy M. Harkless
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
7,154 |
16,885
(0%)
|
0%
|
|
0
|
Common Stock |
Donaldson Co. Inc.
|
Willard D. Oberton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
7,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Donaldson Co. Inc.
|
Willard D. Oberton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.43 per share. |
04 Jun 2025 |
7,000 |
36,661
(0%)
|
0%
|
28.4 |
199,010
|
Common Stock |
Donaldson Co. Inc.
|
Willard D. Oberton
|
Director |
Sale of securities on an exchange or to another person at price $ 69.51 per share. |
04 Jun 2025 |
7,000 |
29,661
(0%)
|
0%
|
69.5 |
486,570
|
Common Stock |
Itron Inc.
|
John F. Marcolini
|
SVP, Networked Solutions |
Sale of securities on an exchange or to another person at price $ 119.50 per share. |
04 Jun 2025 |
6,904 |
14,961
(0%)
|
0%
|
119.5 |
825,028
|
Common Stock |
Paycom Software Inc
|
Chad Richison
|
Director, CEO, President and Chairman, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 265.31 per share. |
04 Jun 2025 |
6,700 |
3,217,349
(5%)
|
0%
|
265.3 |
1,777,577
|
Common Stock |
Chipotle Mexican Grill
|
Curtis Evander Garner
|
Pres, Chief Strgy & Tech Off |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.20 per share. |
04 Jun 2025 |
6,698 |
441,784
(1%)
|
0%
|
52.2 |
349,636
|
common stock |
Cedar Fair L.P.
|
Brian M. Nurse
|
Chief Legal Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.11 per share. |
04 Jun 2025 |
6,508 |
90,338
(0%)
|
0%
|
33.1 |
215,480
|
Common Stock, par value $0.01 per share |
Orange County Bancorp Inc
|
Jonathan Schiller
|
Director |
Purchase of securities on an exchange or from another person at price $ 23.25 per share. |
04 Jun 2025 |
6,451 |
12,446
|
-
|
23.3 |
149,986
|
Common Stock |
Hycroft Mining Holding Cor...
|
Diane R. Garrett
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 3.08 per share. |
04 Jun 2025 |
6,423 |
233,051
|
-
|
3.1 |
19,783
|
Class A Common Stock |
CarGurus Inc - Ordinary Sh...
|
Lori A. Hickok
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,248 |
46,915
(0%)
|
0%
|
|
0
|
Class A Common Stock |
CarGurus Inc - Ordinary Sh...
|
Greg M. Schwartz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,248 |
16,377
(0%)
|
0%
|
|
0
|
Class A Common Stock |
CarGurus Inc - Ordinary Sh...
|
Stephen Kaufer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,248 |
293,173
(0%)
|
0%
|
|
0
|
Class A Common Stock |
CarGurus Inc - Ordinary Sh...
|
Steven Conine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,248 |
53,050
(0%)
|
0%
|
|
0
|
Class A Common Stock |
CarGurus Inc - Ordinary Sh...
|
Manik Gupta
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,248 |
16,798
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Vail Resorts Inc.
|
Robert A. Katz
|
Director, CEO & Chairperson of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
6,144 |
6,144
|
-
|
|
-
|
Restricted Share Unit |
Granite Ridge Resources In...
|
Luke C. Brandenberg
|
President and CEO |
Purchase of securities on an exchange or from another person at price $ 5.80 per share. |
04 Jun 2025 |
6,100 |
157,267
|
-
|
5.8 |
35,380
|
Common Stock, par value $0.0001 per share |
Semtech Corp.
|
Asaf Silberstein
|
EVP and COO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
6,096 |
109,996
(0%)
|
0%
|
38.1 |
232,319
|
Common Stock |
Semtech Corp.
|
Mark Lin
|
EVP and CFO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
6,083 |
20,352
(0%)
|
0%
|
38.1 |
231,823
|
Common Stock |
Varonis Systems Inc
|
Fred van Den Bosch
|
Director |
Sale of securities on an exchange or to another person at price $ 50.00 per share. |
04 Jun 2025 |
6,000 |
131,666
(0%)
|
0%
|
50 |
300,000
|
Common Stock, par value $0.001 per share |
Broadridge Financial Solut...
|
Maura A. Markus
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,771 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Broadridge Financial Solut...
|
Maura A. Markus
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.37 per share. |
04 Jun 2025 |
5,771 |
34,448
(0%)
|
0%
|
56.4 |
325,311
|
Common Stock |
Atlassian Corporation - Or...
|
Scott Farquhar
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 210.75 per share. |
04 Jun 2025 |
5,758 |
15,896
(0%)
|
0%
|
210.8 |
1,213,519
|
Class A Common Stock |
Atlassian Corporation - Or...
|
Michael Cannon-Brookes
|
Director, CEO, Co-Founder, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 210.75 per share. |
04 Jun 2025 |
5,757 |
18,087
(0%)
|
0%
|
210.8 |
1,213,308
|
Class A Common Stock |
Globe Life Inc
|
Frank M. Svoboda
|
Director, Co-Chairman & CEO |
Sale of securities on an exchange or to another person at price $ 121.19 per share. |
04 Jun 2025 |
5,551 |
33,247
(0%)
|
0%
|
121.2 |
672,743
|
Common Stock |
Graham Corp.
|
Daniel J. Thoren
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,542 |
340,661
(3%)
|
0%
|
|
0
|
Common Stock |
Graham Corp.
|
Daniel J. Thoren
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,542 |
11,086
|
-
|
|
-
|
Restricted Stock Units |
Semtech Corp.
|
Madhusudhan Rayabhari
|
SVP and GM |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
5,534 |
61,478
(0%)
|
0%
|
38.1 |
210,901
|
Common Stock |
Verisk Analytics Inc
|
Nicholas Daffan
|
Chief Information Officer |
Sale of securities on an exchange or to another person at price $ 318.10 per share. |
04 Jun 2025 |
5,419 |
56,701
(0%)
|
0%
|
318.1 |
1,723,784
|
Common Stock |
Dave Inc - Ordinary Shares...
|
Yadin Rozov
|
Director |
Sale of securities on an exchange or to another person at price $ 206.92 per share. |
04 Jun 2025 |
5,400 |
95,778
|
-
|
206.9 |
1,117,368
|
Class A Common Stock |
Semtech Corp.
|
Paul V. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Ye Jane Li
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Saar Gillai
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Julie Garcia Ruehl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Rodolpho C. Cardenuto
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Semtech Corp.
|
Gregory Michael Fischer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,321 |
5,321
|
-
|
|
-
|
Restricted Stock Unit |
Chubb Limited
|
Joseph F Wayland
|
Executive Vice President and* |
Sale of securities on an exchange or to another person at price $ 293.16 per share. |
04 Jun 2025 |
5,261 |
66,567
(0%)
|
0%
|
293.2 |
1,542,315
|
Common Shares |
Keros Therapeutics Inc
|
Carl L. Gordon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Jean-Jacques Bienaime
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,450
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Tomer Kariv
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Ran Nussbaum
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Alpna Seth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Nima Farzan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
5,250
|
-
|
|
0
|
Common Stock |
Keros Therapeutics Inc
|
Julius Knowles
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,250 |
6,441
|
-
|
|
0
|
Common Stock |
CarGurus Inc - Ordinary Sh...
|
Ismail Elshareef
|
Chief Product Officer |
Sale of securities on an exchange or to another person at price $ 31.37 per share. |
04 Jun 2025 |
5,246 |
107,007
(0%)
|
0%
|
31.4 |
164,567
|
Class A Common Stock |
Academy Sports and Outdoor...
|
Kenneth C. Hicks
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
Academy Sports and Outdoor...
|
Kenneth C. Hicks
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,218 |
446,024
|
-
|
|
-
|
Common Stock |
American Public Education Inc
|
James Kenigsberg
|
Director |
Sale of securities on an exchange or to another person at price $ 28.03 per share. |
04 Jun 2025 |
5,136 |
24,448
(0%)
|
0%
|
28.0 |
143,976
|
Common Stock, par value $.01 |
Crexendo Inc
|
Jeffrey G. Korn
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
249,013
|
-
|
|
0
|
Common Stock |
Crexendo Inc
|
Jeffrey G. Korn
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
55,000
|
-
|
|
-
|
Restricted Stock Units |
Crexendo Inc
|
Jeffrey G. Korn
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
249,013
|
-
|
|
0
|
Common Stock |
Crexendo Inc
|
Doug Gaylor
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
235,610
|
-
|
|
0
|
Common Stock |
Crexendo Inc
|
Doug Gaylor
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
55,000
|
-
|
|
-
|
Restricted Stock Units |
Crexendo Inc
|
Ronald Vincent
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
185,686
|
-
|
|
0
|
Common Stock |
Crexendo Inc
|
Ronald Vincent
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
55,000
|
-
|
|
-
|
Restricted Stock Units |
Mannatech Inc
|
J. Stanley Fredrick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
20,000
|
-
|
|
-
|
Right to Purchase Common Stock |
Mannatech Inc
|
Tyler Rameson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
5,000 |
16,667
|
-
|
|
-
|
Right to Purchase Common Stock |
Spectral AI Inc - Ordinary...
|
Martin Christopher Bagot Mellish
|
Director |
Grant, award, or other acquisition of securities at price $ 1.73 per share. |
04 Jun 2025 |
5,000 |
24,398
|
-
|
1.7 |
8,650
|
Common Stock |
Ameresco Inc. - Ordinary S...
|
Nickolas Stavropoulos
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
14,111
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ameresco Inc. - Ordinary S...
|
Nickolas Stavropoulos
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Joseph Sutton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Joseph Sutton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
50,111
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ameresco Inc. - Ordinary S...
|
Frank V. Wisneski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
25,232
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ameresco Inc. - Ordinary S...
|
Frank V. Wisneski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Jennifer L. Miller
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
22,111
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ameresco Inc. - Ordinary S...
|
Jennifer L. Miller
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Claire D'Oyly-Hughes Johnson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Ameresco Inc. - Ordinary S...
|
Claire D'Oyly-Hughes Johnson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
4,886 |
10,111
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Dolphin Entertainment Inc.
|
William O’Dowd
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 1.08 per share. |
04 Jun 2025 |
4,600 |
210,529
(1%)
|
0%
|
1.1 |
4,968
|
Common Stock |
Helmerich & Payne, Inc.
|
Sara M. Momper
|
VP, CAO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,567 |
28,608
(0%)
|
0%
|
|
0
|
Common Stock |
Hycroft Mining Holding Cor...
|
Stanton K. Rideout
|
Executive Vice President & CFO |
Sale of securities on an exchange or to another person at price $ 3.81 per share. |
04 Jun 2025 |
4,398 |
132,986
|
-
|
3.8 |
16,756
|
Class A Common Stock |
Sphere Entertainment Co - ...
|
Thomas C. Dolan
|
Director, Member of 13(d) Group |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
28,786
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Vincent S. Tese
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
19,154
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Brian G. Sweeney
|
Director, Trustee of 13(d) Group Member |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
28,786
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Marianne Dolan Weber
|
Director, Member of 13(d) Group |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
19,154
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Charles P. Dolan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
19,154
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Debra G. Perelman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
4,397
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
John L. Sykes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
25,919
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Quentin F. Dolan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
19,154
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Joel M. Litvin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
24,083
|
-
|
|
-
|
Restricted Stock Units |
Sphere Entertainment Co - ...
|
Isiah L. Thomas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,397 |
19,154
|
-
|
|
-
|
Restricted Stock Units |
Modine Manufacturing Co.
|
Neil D. Brinker
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.66 per share. |
04 Jun 2025 |
4,305 |
272,948
(0%)
|
0%
|
91.7 |
394,596
|
Common stock |
AVITA Medical Inc
|
Jeremy L. Curnock Cook
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
AVITA Medical Inc
|
Robert E. Mcnamara
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
AVITA Medical Inc
|
Jan Stern Reed
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
AVITA Medical Inc
|
Cary G. Vance
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
AVITA Medical Inc
|
Louis J. Panaccio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
AVITA Medical Inc
|
Suzanne Crowe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
4,295 |
4,295
|
-
|
|
-
|
Stock Options (Right to Buy) |
Semtech Corp.
|
J. Michael Wilson
|
Chief Quality Officer and CTO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
4,248 |
65,066
(0%)
|
0%
|
38.1 |
161,891
|
Common Stock |
Semtech Corp.
|
Imran Sherazi
|
SVP and GM |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
4,090 |
8,818
(0%)
|
0%
|
38.1 |
155,870
|
Common Stock |
Semtech Corp.
|
William Ross Gray
|
SVP and GM |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.11 per share. |
04 Jun 2025 |
4,087 |
15,987
(0%)
|
0%
|
38.1 |
155,756
|
Common Stock |
Semtech Corp.
|
Mark Lin
|
EVP and CFO |
Sale of securities on an exchange or to another person at price $ 37.96 per share. |
04 Jun 2025 |
3,763 |
16,589
(0%)
|
0%
|
38.0 |
142,832
|
Common Stock |
Bridgewater Bancshares Inc
|
Lisa M. Salazar
|
CHIEF OPERATING OFFICER |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
04 Jun 2025 |
3,737 |
32,335
(0%)
|
0%
|
14.4 |
53,813
|
Common Stock |
Itron Inc.
|
Thomas L. Deitrich
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 120.16 per share. |
04 Jun 2025 |
3,710 |
262,028
(0%)
|
0%
|
120.2 |
445,810
|
Common Stock |
Broadridge Financial Solut...
|
Maura A. Markus
|
Director |
Sale of securities on an exchange or to another person at price $ 243.08 per share. |
04 Jun 2025 |
3,556 |
30,892
(0%)
|
0%
|
243.1 |
864,408
|
Common Stock |
Leonardo DRS Inc.
|
Mary E. Gallagher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Leonardo DRS Inc.
|
Kenneth J. Krieg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Leonardo DRS Inc.
|
Frances Fragos Townsend
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Leonardo DRS Inc.
|
Eric C. Salzman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Leonardo DRS Inc.
|
George W. Casey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Leonardo DRS Inc.
|
Gail S. Baker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2025 |
3,556 |
3,556
|
-
|
|
-
|
Restricted Stock Unit |
Cognizant Technology Solut...
|
Joseph Mark Velli
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
3,417 |
0
|
-
|
|
-
|
Restricted Stock Units |
Cognizant Technology Solut...
|
Joseph Mark Velli
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
3,417 |
26,800
(0%)
|
0%
|
|
-
|
Class A Common Stock |